Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

Merck
CN

LC/MS Analysis of Omeprazole and Metabolites in Plasma on Ascentis® Express RP Amide after Sample Prep using HybridSPE®-Phospholipid

LC/MS Analysis of Omeprazole and Metabolites in Plasma on Ascentis® Express RP Amide after Sample Prep using HybridSPE®-Phospholipid application for HPLC, application for SPE

Materials

analytical column

Product No.
Description
Pricing

Ascentis® Express RP-Amide, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 5 cm × 2.1 mm

SPE tube or plate

Product No.
Description
Pricing

HybridSPE®-Phospholipid

96-well Plate, bed wt. 50 mg, volume 2 mL, pk of 1

standard

Product No.
Description
Pricing

Phenacetin

≥98.0% (HPLC)

Omeprazole sulfone

analytical standard

5-Hydroxyomeprazole

analytical standard

Omeprazole

analytical standard

CONDITIONS

sample preparation

SPE (Solid Phase Extraction)

sample/matrix

rat plasma spiked with omeprazole, phenacetin and metabolites at 2 μg/mL

SPE well plate

HybridSPE-Phospholipid, 96-well plate, 15 mg/0.8 mL (575656-U)

sample addition

100 μL plasma to each well, followed by 300 mL of 1% formic acid in acetonitrile

elution

apply vacuum

eluate post-treatment

eluate was collected, evaporated, and reconstituted in mobile phase.

column

Ascentis Express RP-Amide, 5 cm x 2.1 mm I.D., 2.7 μm particles (53911-U)

mobile phase

[A] water, 10 mM ammonium formate, pH 3.4; [B] methanol, 10 mM ammonium formate, pH 3.4; (65:35, A:B)

flow rate

0.3 mL/min

column temp.

35 °C

detector

ESI(+), m/z = 50-400

injection

1 μL

Description

Application

This application demonstrates the suitability of HybridSPE and the Ascentis Express RP Amide for the analysis of omeprazole metabolites.

Analysis Note

Sample was vorlexed and centrifuged for 2 minutes at 15000 rpm. Supemate was then passed through HybridSPE 96 well plate. Elutent was collected, evaporated and reconstituted in mobile phase.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany